A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma

  • Ivana N.M. Micallef
  • , Brad S. Kahl
  • , Matthew J. Maurer
  • , Ahmet Dogan
  • , Stephen M. Ansell
  • , Joseph P. Colgan
  • , Susan Geyer
  • , David J. Inwards
  • , William L. White
  • , Thomas M. Habermann

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science